JAYDESS Drug Utilization Study in Sweden

Bayer

Status: Completed

Conditions: Contraception

Treatments: Drug: Levonorgestrel (Jaydess, Skyla, BAY86-5028)

Study type: Observational

Funder types: Industry; Other

Identifiers

NCT02349815

16903

JD1311SE (Other Identifier)

Details and patient eligibility

About

• To describe characteristics (demographic, clinical, social) of first time users of Jaydess
• To estimate the duration of use of Jaydess
• To study switching patterns, e.g. what are the hormonal contraceptive methods used before and what are the methods after discontinuing Jaydess
• To study off-label use of Jaydess

Enrollment: 10,000 patients

Sex: Female

Ages: 18 to 64 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Swedish women who were dispensed a JAYDESS from a Swedish Pharmacy anytime 2014-2017

Exclusion criteria

No exclusion criteria

Trial design

10,000 participants in 1 patient group

Group 1

Description:

Women prescribed JAYDESS in Sweden

Treatment:

Drug: Levonorgestrel (Jaydess, Skyla, BAY86-5028)